Castles Technology Co., Ltd. (5258)

Overview

Shinpoong Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company with a comprehensive portfolio of products and a significant global presence. Founded in 1962, the company has grown to become a notable player in the pharmaceutical industry, both domestically and internationally. Shinpoong Pharmaceutical manufactures and sells a wide range of pharmaceutical products, involving active pharmaceutical ingredients and finished products. Its operations encompass not just the production of various drugs but also extend to business management and international exports. With its products reaching around 50 countries, Shinpoong Pharmaceutical is committed to improving health care worldwide. The company's headquarters is located in Seoul, South Korea, serving as a central hub for its extensive research, development, and manufacturing activities.

Products and Services

Shinpoong Pharmaceutical Co., Ltd. offers an extensive lineup of pharmaceutical products and services, characterized by innovation and quality. These include:

• Cephalosporin Antibiotics - A class of beta-lactam antibiotics used in the treatment of bacterial infections by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls.
• Penicillin Antibiotics - Another group of beta-lactam antibiotics effective against a range of bacterial infections, working by inhibiting cell wall synthesis.
• Antivirals - Medications designed to treat viral infections by inhibiting the development of the virus within the host cell.
• Anticancer Drugs - A broad range of medications used in the treatment of cancer, targeting various aspects of cancer cell growth and proliferation.
• Painkillers and Anti-inflammatory Products - Medications intended for the relief of pain and inflammation, catering to various needs and conditions.
• Anthelmintics - Drugs used to treat parasitic worm infections by causing neuromuscular paralysis of the worms.
• Active Pharmaceutical Ingredients (APIs) - The biologically active components of drugs, responsible for the intended effects of pharmaceutical products.
• Pyramax - An anti-malarial drug, signifying a significant advancement in the treatment of malaria with its innovative formulation.
• Hypercholesterolemia Treatment - Medications aimed at reducing cholesterol levels in the blood, thus preventing cardiovascular diseases.
• Knee Osteoarthritis and Shoulder Periarthritis Treatment - Specialized drugs designed to alleviate the symptoms and slow the progression of these joint disorders.
• Surgical Adhesion Barrier - A product used to prevent post-surgical adhesions, enhancing recovery and reducing complications after surgeries.
• Prescription Drugs - A wide array of medications available only with a doctor's prescription, covering a multitude of health conditions and diseases.
• Wound Dressings - Products specifically designed to protect wounds and promote their optimal healing.
• Health Functional Food - Foods that are formulated to provide health benefits beyond basic nutrition, supporting overall well-being.
• Over the Counter Products - A range of medications and health products available without a prescription, for convenience and ease of access.

In addition to its comprehensible portfolio of pharmaceutical products, Shinpoong Pharmaceutical is engaged in business management activities and leverages its expertise to facilitate a thriving export business, distributing its innovations to a global audience.